by European Public Health Alliance | Jul 14, 2022 | Antimicrobial Resistance (AMR), Antimicrobial Resistance | Analysis & Opinion
In its current revision of the EU pharmaceutical legislation, the European Commission (EC) plans to address the increasing burden of antibiotic resistance (AMR) by setting up incentives for the development of new antibiotics. With increasing antimicrobial...
by European Public Health Alliance | May 31, 2022 | Antimicrobial Resistance | Analysis & Opinion
Guest article by Calum MacKichan & Sarah de Maaker – Standing Committee of European Doctors (CPME) The problem of antimicrobial resistance (AMR) is faced by doctors across Europe on a daily basis who are unable to successfully treat patients who have...
by European Public Health Alliance | May 31, 2022 | Antimicrobial Resistance | Publications
By Kirsty Douglas – Policy Assistant for Global Public Health Antimicrobial resistance (AMR) is an ongoing public health crisis, with a recent report associating bacterial AMR with 4.95 deaths per year worldwide, including 1.27 million attributable deaths. This is a...
by European Public Health Alliance | May 31, 2022 | Antimicrobial Resistance | Analysis & Opinion
Guest article by David Garrahy – World Animal Protection Human health and well-being are intrinsically linked to animal health and welfare. The interconnectedness of both in a healthy environment is the key concept of the One Health policy approach that the European...
by European Public Health Alliance | May 31, 2022 | Antimicrobial Resistance | Analysis & Opinion
The image shows Staphylococcus aureus bacteria. Source: HZI/Manfred Rohde. Guest article by Jens Jäger – Delegate for Health Research at the Helmholtz Office in Brussels. Twitter: @JensJot. Knowledge is power – an old saying with tremendous meaning today. In the...
by European Public Health Alliance | May 17, 2022 | Antimicrobial Resistance | Latest Developments
On the 19th of April, the European Commission published a draft list of antimicrobials to be reserved for human health, based on the European Medicines Agency’s recommendation. The list has been severely criticized because its implementation may compromise the...
